Method for processing serum or (plasma) specimens using a centrifuge
Release time:
2014-07-22
Overview:
After receiving clinical specimens, the laboratory should promptly use a serum centrifuge to perform low-speed centrifugation and separate the serum or plasma for subsequent analysis. By incubating the samples in a 45℃ water bath for 10 minutes and then centrifuging at 3,000 rpm for 5 minutes, levels of LDH, K, and other analytes can be significantly elevated. Visual inspection of blood specimens is the most straightforward method for assessing specimen quality. Abnormal appearances—such as hemolysis, jaundice, or lipemia—are among the most common causes of measurement errors.
(1) For the centrifugal separation of serum from specimens, the relative centrifugal force (RCF) of the centrifuge should be set at 1000g to 1200g, and the centrifugation time should be 5 to 10 minutes. Increasing either the relative centrifugal force or the centrifugation time can easily lead to hemolysis.
(2) Handling of Hemolyzed Specimens: Hemolysis can lead to the release of various components from RBCs, thereby interfering with assay methods. Hemoglobin (Hb) levels ≥0.2 g/L indicate visible hemolysis.
① Indirect interference: The release of hemoglobin can cause indirect interference, as hemoglobin exhibits light absorption at wavelengths of 431 nm and 555 nm. If the analyte being measured is analyzed colorimetrically using wavelengths close to these, it may lead to falsely elevated results. Treatment methods: For mild hemolysis, perform a serum blank simultaneously; for severe hemolysis, re-collect the sample.
② Direct interference: After hemolysis, blood chemical components that are present in high concentrations within RBCs will show increased concentrations in the serum. Therefore, avoid using hemolyzed specimens for determining chemical components that are abundant in RBCs, such as potassium, ALP, AST, bilirubin, CK, LD, and ACP.
(3) Handling of Chylous Specimens: Patients with hyperlipidemia often develop chylous blood. To avoid interference with testing, chylous blood must be clarified. The specific procedure is as follows: Mix serum and/or plasma with Freon in a 1:1 ratio in a glass test tube. Place the tube upside down at 180℃ for 3 minutes to ensure thorough mixing. Then, centrifuge at 3000g for 6 minutes. The supernatant will be clear serum, the middle layer will contain precipitated lipoproteins, and the bottom layer will consist of excess Freon. This clarification process can be repeated multiple times without affecting enzyme activity or substrate performance.
(4) Handling of Bilirubin (Jaundice) Samples: The color of bilirubin can interfere positively with colorimetric analyses that rely on yellow and red compounds as reaction products. This interference can be eliminated by using a sample blank or employing kinetic and two-reagent methods. Additionally, bilirubin is unstable and tends to degrade into biliverdin and bilirubin brown under alkaline conditions or exposure to strong light, resulting in fading of the color. For instance, when creatinine is measured using the alkaline picric acid method, jaundiced samples often yield negative results. Furthermore, bilirubin exhibits reducing properties, which can negatively interfere with Trinder reactions—for example, in enzymatic assays for glucose, cholesterol, triglycerides, uric acid, and other analytes. Constant errors caused by such interference can be eliminated through appropriate interference tests.
Previous: